Propensity score analysis with partially observed covariates: How should multiple imputation be used?


Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 3 6 2017
medline: 2 5 2020
entrez: 3 6 2017
Statut: ppublish

Résumé

Inverse probability of treatment weighting is a popular propensity score-based approach to estimate marginal treatment effects in observational studies at risk of confounding bias. A major issue when estimating the propensity score is the presence of partially observed covariates. Multiple imputation is a natural approach to handle missing data on covariates: covariates are imputed and a propensity score analysis is performed in each imputed dataset to estimate the treatment effect. The treatment effect estimates from each imputed dataset are then combined to obtain an overall estimate. We call this method MIte. However, an alternative approach has been proposed, in which the propensity scores are combined across the imputed datasets (MIps). Therefore, there are remaining uncertainties about how to implement multiple imputation for propensity score analysis: (a) should we apply Rubin's rules to the inverse probability of treatment weighting treatment effect estimates or to the propensity score estimates themselves? (b) does the outcome have to be included in the imputation model? (c) how should we estimate the variance of the inverse probability of treatment weighting estimator after multiple imputation? We studied the consistency and balancing properties of the MIte and MIps estimators and performed a simulation study to empirically assess their performance for the analysis of a binary outcome. We also compared the performance of these methods to complete case analysis and the missingness pattern approach, which uses a different propensity score model for each pattern of missingness, and a third multiple imputation approach in which the propensity score parameters are combined rather than the propensity scores themselves (MIpar). Under a missing at random mechanism, complete case and missingness pattern analyses were biased in most cases for estimating the marginal treatment effect, whereas multiple imputation approaches were approximately unbiased as long as the outcome was included in the imputation model. Only MIte was unbiased in all the studied scenarios and Rubin's rules provided good variance estimates for MIte. The propensity score estimated in the MIte approach showed good balancing properties. In conclusion, when using multiple imputation in the inverse probability of treatment weighting context, MIte with the outcome included in the imputation model is the preferred approach.

Identifiants

pubmed: 28573919
doi: 10.1177/0962280217713032
pmc: PMC6313366
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-19

Subventions

Organisme : Medical Research Council
ID : G0802403
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/21
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M013278/1
Pays : United Kingdom

Références

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):393-401
pubmed: 17066486
Stat Methods Med Res. 2016 Feb;25(1):188-204
pubmed: 22687877
Stat Methods Med Res. 2015 Aug;24(4):462-87
pubmed: 24525487
Stat Med. 2007 Jul 20;26(16):3078-94
pubmed: 17187347
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
pubmed: 21499542
Stat Med. 2014 Jan 15;33(1):74-87
pubmed: 23787715
Stat Med. 2010 Dec 10;29(28):2920-31
pubmed: 20842622
J Pediatr Surg. 2008 May;43(5):924-7
pubmed: 18485967
BMC Public Health. 2016 Aug 17;16:804
pubmed: 27534527
Stat Med. 2009 Apr 30;28(9):1402-14
pubmed: 19222021
Stat Methods Med Res. 2017 Jun;26(3):1199-1215
pubmed: 25715391
Stat Med. 2014 Feb 28;33(5):721-37
pubmed: 24114884
Ann Intern Med. 2014 Nov 18;161(10):699-710
pubmed: 25402513
Stat Med. 2004 Oct 15;23(19):2937-60
pubmed: 15351954
Inform Prim Care. 2011;19(4):251-5
pubmed: 22828580
Urology. 2016 Sep;95:121-7
pubmed: 27179773
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
J Pediatr Surg. 2015 Jan;50(1):171-6
pubmed: 25598118
BMJ. 2011 Apr 06;342:d1642
pubmed: 21471172
Stat Methods Med Res. 2016 Dec;25(6):3066-3068
pubmed: 27852808
Rheumatology (Oxford). 2014 Apr;53(4):757-63
pubmed: 24369411
Stat Med. 2014 Mar 15;33(6):1057-69
pubmed: 24123228
Drug Saf. 2015 Jun;38(6):589-600
pubmed: 25935198
J Clin Epidemiol. 2006 Oct;59(10):1092-101
pubmed: 16980150
PLoS One. 2016 Dec 1;11(12):e0166444
pubmed: 27907084
N Engl J Med. 2000 Jun 22;342(25):1887-92
pubmed: 10861325

Auteurs

Clémence Leyrat (C)

1 Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK.

Shaun R Seaman (SR)

2 MRC Biostatistics Unit, Cambridge Institute for Public Health, Cambridge, UK.

Ian R White (IR)

2 MRC Biostatistics Unit, Cambridge Institute for Public Health, Cambridge, UK.
3 London Hub for Trials Methodology Research, MRC Clinical Trials Unit, UCL, London, UK.

Ian Douglas (I)

4 Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, UK.

Liam Smeeth (L)

4 Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, UK.

Joseph Kim (J)

1 Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK.
5 IMS Health, Real-World Evidence Solutions, UK.

Matthieu Resche-Rigon (M)

6 SBIM Biostatistics and Medical Information, Hôpital Saint-Louis, France.
7 ECSTRA Team (Epidémiologie Clinique et Statistiques pour la Recherche en Santé), UMR 1153 INSERM, Université Paris Diderot, France.

James R Carpenter (JR)

1 Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK.
3 London Hub for Trials Methodology Research, MRC Clinical Trials Unit, UCL, London, UK.

Elizabeth J Williamson (EJ)

1 Department of Medical Statistics, London School of Hygiene and Tropical Medicine, UK.
8 Farr Institute of Health Informatics, London University College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH